Summary
We have used intracerebral dialysis to monitor the striatal extracellular fluid (ECF) in rats with unilateral lesions of the nigrostriatal dopamine (DA) pathway. Dialysis samples were collected before and after L-dihydroxyphenylalanine (L-DOPA) administration both in the presence and absence of carbidopa, an extracerebral DOPA decarboxylase (DDC) inhibitor. The baseline ECF levels of DA, 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) were always higher in the intact than in the lesioned striata. In the normal striata, dopamine (DA) concentrations increased following L-DOPA administration. Pretreatment with carbidopa prolonged the duration of the DA increase. In the lesioned striata, DA levels increased following L-DOPA administration only in animals pretreated with carbidopa. Following L-DOPA administration, striatal HVA and DOPAC levels increased considerably more in animals not pretreated with carbidopa than they did in pretreated animals. This increase was particularly marked in the lesioned striata and leads us to conclude that extracerebrally produced HVA and DOPAC can enter the brain extracellular space.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hefti F, Melamed E, Wurtman RJ (1980) Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res 195: 123–137
Hefti F, Melamed E, Wurtman RJ (1981) The site of dopamine formation after L-Dopa administration. J Pharmacol Exp Ther 217: 189–197
Hornykiewicz O, Kish SJ (1986) Biochemical pathophysiology of Parkinson's disease. In: Yahr MD, Bergman KJ (eds) Advances in neurology, vol 45, Parkinson's disease. Raven Press, New York, pp 19–34
Melamed E, Hefti F, Bitton V, Globus M (1984) Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism. Neurology 34: 1566–1570
Phebus LA, Perry KW, Clemens JA, Fuller RW (1986) Brain anoxia releases striatal dopamine in rats. Life Sci 38: 2447–2453
Sharp T, Zetterstrom T, Ungerstedt U (1986) An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis. J Neurochem 47: 113–122
Ungerstedt U (1984) Measurement of neurotransmitter release by intracranial dialysis. In: Marsden CA (ed) Measurement of neurotransmitter release in vivo. Wiley, New York, pp 81–105
Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand [Suppl] 367: 69–91
Yahr MD, Bergman KJ (eds) Advances in neurology, vol 45, Parkinson's disease. Raven Press, New York, pp 457–510
Zetterstrom T, Brundin P, Gage FH, Sharp T, Isacson O, Dunnett SB, Unterstedt U, Bjorklund A (1986 a) In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis. Brain Res 362: 344–349
Zetterstrom T, Herrera-Marchitz M, Ungerstedt U (1986 b) Simultaneous measurement of dopamine release and rotational behavior in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res 376: 1–7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brannan, T., Knott, P., Kaufmann, H. et al. Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-DOPA. J. Neural Transmission 75, 149–157 (1989). https://doi.org/10.1007/BF01677428
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01677428